Access Biotechnology
Part of Access Industries
Access Biotechnology is the biopharma investment division of Access Industries, the New York- and London-based investment company founded by Len Blavatnik in 1986. Established in 2019 and led by Liam Ratcliffe, former head of worldwide clinical R&D at Pfizer, it invests in private and public biotech companies developing transformative therapies across therapeutic areas and stages from discovery platforms to late-stage clinical programs, with 40+ investments and 10+ exits.
New York, United States · 1+ investments · 1 portfolio companies
- Headquarters
- New York, United States
- Founded
- 2019
- Website
- accessindustries.com
- Portfolio Company
- 1
- Total Investment
- 1
- Last Investment
- Mar 2025
- Geographic Focus
- United States
Overview
Access Biotechnology is a Corporate VC firm based in New York, United States. It has made 1 investment, including Latigo Biotherapeutics.
Access Industries Family
Portfolio1
Co-investors9
Sign up to view co-investors
9 co-investors across 9 shared portfolio companies — who they back alongside, and how often they lead.
Venture Capital ×4 · Private Equity ×2 · Corporate VC ×1 · 5 shared rounds
Investment History
Sign up to view investment history
Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.
Your firm? Embed this profile
Add the live badge to your site — it stays current as your portfolio data updates.
<a href="https://indexed.vc/investors/access-biotechnology"><img src="https://indexed.vc/api/badge/investor/access-biotechnology" alt="Access Biotechnology on Indexed.vc" width="260" height="76" /></a>